Stockscreener 앱 받기
2.34
2.63%
0.06
시간 외 거래:
2.35
0.01
+0.43%
전일 마감가:
$2.28
열려 있는:
$2.22
하루 거래량:
26,251
Relative Volume:
0.02
시가총액:
$28.78M
수익:
$22.06M
순이익/손실:
$-30.94M
주가수익비율:
-1.0446
EPS:
-2.24
순현금흐름:
$-26.70M
1주 성능:
+1.30%
1개월 성능:
+20.62%
6개월 성능:
+2.63%
1년 성능:
-64.27%
1일 변동 폭
$2.21
$2.38
1주일 범위
$2.14
$2.50
52주 변동 폭
$1.0909
$7.67
Casi Pharmaceuticals Inc Stock (CASI) Company Profile
CASI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CASI
Casi Pharmaceuticals Inc
|
2.34 | 35.32M | 22.06M | -30.94M | -26.70M | -2.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Casi Pharmaceuticals Inc Stock (CASI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-05-18 | 개시 | BTIG Research | Buy |
| 2021-04-26 | 개시 | Mizuho | Buy |
| 2020-10-23 | 개시 | Oppenheimer | Outperform |
| 2016-09-22 | 개시 | Maxim Group | Buy |
| 2015-10-29 | 재개 | H.C. Wainwright | Buy |
| 2015-06-23 | 개시 | H.C. Wainwright | Buy |
모두보기
Casi Pharmaceuticals Inc 주식(CASI)의 최신 뉴스
What to expect from CASI Pharmaceuticals Inc. in the next 30 daysTrade Ideas & Safe Swing Trade Setup Alerts - Newser
Using RSI to spot recovery in CASI Pharmaceuticals Inc.Portfolio Profit Report & Weekly Top Performers Watchlists - Newser
Breakouts Watch: Can CASI Pharmaceuticals Inc. deliver consistent EPS growth2025 Fundamental Recap & Intraday High Probability Setup Alerts - خودرو بانک
Can CASI Pharmaceuticals Inc. sustain its profitabilityQuarterly Trade Summary & Weekly Breakout Stock Alerts - خودرو بانک
Is CASI Pharmaceuticals Inc. stock good for income investorsPortfolio Growth Summary & Real-Time Buy Signal Notifications - خودرو بانک
Does CASI Pharmaceuticals Inc. have consistent dividend growthJuly 2025 Earnings & Daily Volume Surge Signals - خودرو بانک
Should you wait for a breakout in CASI Pharmaceuticals Inc.2025 Market Overview & Precise Buy Zone Tips - Newser
Best data tools to analyze CASI Pharmaceuticals Inc. stock2025 Trade Ideas & Real-Time Volume Analysis Alerts - Newser
Can a trend reversal in CASI Pharmaceuticals Inc. lead to recoveryGDP Growth & Community Verified Trade Signals - Newser
Can CASI Pharmaceuticals Inc. deliver consistent EPS growthPortfolio Return Summary & High Accuracy Investment Entry Signals - خودرو بانک
Will CASI Pharmaceuticals Inc. benefit from sector rotation2025 EndofYear Setup & Verified Swing Trading Watchlists - خودرو بانک
What is CASI Pharmaceuticals Inc.’s valuation compared to sectorWeekly Earnings Recap & Safe Capital Growth Tips - خودرو بانک
How to escape a deep drawdown in CASI Pharmaceuticals Inc.July 2025 Outlook & Reliable Intraday Trade Plans - Newser
What momentum shifts mean for CASI Pharmaceuticals Inc.Portfolio Risk Report & Entry Point Confirmation Alerts - Newser
What is the next catalyst for CASI Pharmaceuticals Inc.Dividend Hike & Advanced Swing Trade Entry Alerts - خودرو بانک
Can volume confirm reversal in CASI Pharmaceuticals Inc.Market Trend Report & High Return Trade Guides - Newser
CASI Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference - ACCESS Newswire
Volatility clustering patterns for CASI Pharmaceuticals Inc.Portfolio Risk Report & Risk Controlled Swing Trade Alerts - Newser
Risk vs reward if holding onto CASI Pharmaceuticals Inc.2025 Growth vs Value & Technical Pattern Based Buy Signals - Newser
Is CASI Pharmaceuticals Inc. a momentum stockJuly 2025 Patterns & Expert Approved Momentum Ideas - خودرو بانک
Will CASI Pharmaceuticals Inc. rebound enough to break evenTrade Ideas & Free Verified High Yield Trade Plans - Newser
What Fibonacci levels say about CASI Pharmaceuticals Inc. reboundWall Street Watch & Safe Capital Growth Tips - Newser
CASI Pharmaceuticals Faces Setback with FOLOTYN® License Expiration in China - MSN
Advanced analytics toolkit walkthrough for CASI Pharmaceuticals Inc.Portfolio Gains Report & Safe Swing Trade Setups - Newser
What Technical Tools Say About CASI Pharmaceuticals Inc. RecoveryJuly 2025 EndofMonth & Risk Adjusted Buy/Sell Alerts - beatles.ru
CASI Pharmaceuticals Strengthens Board with New Appointment - TipRanks
CASI Pharmaceuticals Appoints Barbara Krebs-Pohl, PhD to Board of Directors - ACCESS Newswire
$2.9B Novartis Deal Expert: CASI Pharma Appoints MorphoSys Ex-CBO to Guide CID-103 Development - Stock Titan
What are CASI Pharmaceuticals Inc.’s recent SEC filings showingMarket Growth Report & Low Drawdown Trading Strategies - خودرو بانک
What drives CASI Pharmaceuticals Inc.’s stock priceWeekly Investment Recap & Real-Time Buy Signal Alerts - خودرو بانک
Is CASI Pharmaceuticals Inc. attractive for institutional investorsMarket Activity Report & AI Enhanced Trade Execution Alerts - خودرو بانک
Candlestick signals on CASI Pharmaceuticals Inc. stock todayJuly 2025 Sentiment & Stepwise Trade Execution Plans - Newser
Can CASI Pharmaceuticals Inc. grow without external funding2025 Earnings Surprises & Growth Focused Entry Point Reports - خودرو بانک
Ranking CASI Pharmaceuticals Inc. among high performing stocks via toolsMarket Volume Report & Technical Entry and Exit Tips - Newser
Combining price and volume data for CASI Pharmaceuticals Inc.July 2025 Gainers & Safe Entry Trade Signal Reports - Newser
How to build a custom watchlist for CASI Pharmaceuticals Inc.July 2025 Recap & Daily Price Action Insights - Newser
Does CASI Pharmaceuticals Inc. show high probability of reboundMarket Performance Recap & Growth Focused Stock Pick Reports - Newser
Using data tools to time your CASI Pharmaceuticals Inc. exitIndex Update & AI Forecasted Entry and Exit Points - Newser
There's No Escaping CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Muted Revenues Despite A 79% Share Price Rise - 富途牛牛
Custom watchlist performance reports with CASI Pharmaceuticals Inc.Gap Down & Low Risk Growth Stock Ideas - Newser
CASI Pharmaceuticals Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Is CASI Pharmaceuticals Inc. forming a reversal patternShare Buyback & Daily Volume Surge Trade Alerts - Newser
Institutional Tools Highlight Unusual Flow in CASI Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Quantitative breakdown of CASI Pharmaceuticals Inc. recent moveEarnings Growth Summary & Stepwise Swing Trade Plans - Newser
Casi Pharmaceuticals Inc (CASI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):